<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)
of the Securities Exchange Act of 1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):&nbsp;
June 11, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Brainstorm Cell Therapeutics Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Exact name of registrant as specified
in its charter) </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 34%; vertical-align: top; font-weight: bold; text-align: center">Delaware</TD>
    <TD STYLE="width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 31%; vertical-align: top; font-weight: bold; text-align: center">000-54365</TD>
    <TD STYLE="width: 1%; vertical-align: top">&nbsp;</TD>
    <TD STYLE="width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 31%; vertical-align: top; font-weight: bold; text-align: center">20-8133057</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; font-style: italic; text-align: center">(State or other jurisdiction of incorporation)</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-style: italic; text-align: center">(Commission File No.)</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-style: italic; text-align: center">(IRS Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold; text-align: center"><B>605 Third Avenue, 34<SUP>th</SUP> Floor </B></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center">New York, NY</TD>
    <TD STYLE="font-weight: bold; text-align: center">10158</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-style: italic; text-align: center">(Address of principal executive offices)</TD>
    <TD STYLE="font-style: italic; text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(646) 666-3188 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Registrant&rsquo;s telephone number,
including area code) </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Former name or former address, if changed
since last report) </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">o </FONT>Written communications
pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">o </FONT>Soliciting material
pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">o </FONT>Pre-commencement
communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">o </FONT>Pre-commencement
communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(c) </I>On June 11, 2012, Brainstorm Cell Therapeutics Inc.
(the &ldquo;Company&rdquo;) appointed <FONT STYLE="color: black">Adrian Harel, Ph.D., as its Chief Executive Officer. Dr. Harel
previously served as the Company&rsquo;s Chief Operating Officer and Acting Chief Executive Officer. In addition to his role as
Chief Executive Officer of the Company, Dr. Harel will continue to serve as the Company&rsquo;s Director of Research and Development.
There were no changes to Dr. Harel&rsquo;s employment terms in connection with the appointment as Chief Executive Officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Company&rsquo;s Form 8-K filed
with the Securities and Exchange Commission on February 2, 2011 and the employment agreement filed as Exhibit 10.1 thereto are
incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>(e)</I> On June 12, 2012, at the Annual Meeting of Stockholders
of the Company, the Company&rsquo;s stockholders approved the amendment and restatement of the Company&rsquo;s 2004 Global Share
Option Plan (the &ldquo;Global Plan&rdquo;) and 2005 U.S. Stock Option and Incentive Plan (collectively, the &ldquo;Plans&rdquo;).
The amendment and restatement of the Plans was approved by the Company&rsquo;s Board of Directors, subject to the approval of the
Company&rsquo;s stockholders, and became effective with such stockholder approval on June 12, 2012. As a result of such stockholder
approval, the Plans were amended to increase the number of shares of the Company&rsquo;s common stock available for issuance under
the Plans by 9,000,000 shares, collectively, and the Global Plan was amended to provide for the issuance of restricted stock and
other equity-based awards under such plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A more complete description of the terms of the Plans and the
amendments thereto can be found in &ldquo;Proposal No.&nbsp;4 &amp; 5 &ndash; Approval of Amendment and Restatement of 2004 Global
Share Option Plan and 2005 U.S. Stock Option and Incentive Plan&rdquo; (pages 11 through 17) in the Company&rsquo;s definitive
proxy statement on Schedule 14A filed with the Securities and Exchange Commission on May 7, 2012. The foregoing descriptions are
qualified in their entirety by reference to the Plans filed as exhibits hereto, which exhibits are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 5.07 Submission of Matters to a Vote of Security Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As stated above in Item&nbsp;5.02, the
2012 Annual Meeting of Stockholders of the Company (the &ldquo;Meeting&rdquo;) was held on June 12, 2012. At the Meeting, the following
matters were voted upon by the stockholders of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px">1.</TD>
    <TD STYLE="text-align: justify">The election of seven directors until the next annual meeting of stockholders;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>2.</TD>
    <TD STYLE="text-align: justify">The approval, on an advisory basis, of the compensation of the Company&rsquo;s named executive officers;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>3.</TD>
    <TD STYLE="text-align: justify">The approval, on an advisory basis, of the frequency of future executive compensation advisory votes;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>4.</TD>
    <TD STYLE="text-align: justify">The amendment and restatement of the  Plans to increase the number of shares of the Company&rsquo;s common stock available for issuance thereunder by 9,000,000 shares, collectively;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>5.</TD>
    <TD STYLE="text-align: justify">The amendment and restatement of the Global Plan to provide for the issuance of restricted
    stock and other equity-based awards under such plan; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>6.</TD>
    <TD STYLE="text-align: justify">The ratification of the appointment of Brightman Almagor &amp; Zohar Co., a member of Deloitte Touche Tohmatsu, as the Company&rsquo;s independent registered public accounting firm for the current fiscal year.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The number of shares of common stock issued,
outstanding and eligible to vote at the Meeting as of the record date of April 23, 2012 was <FONT STYLE="color: black">127,961,217</FONT>.
Each of the matters voted upon at the Meeting was approved by the requisite number of votes. The final results of the voting on
each of the matters presented to stockholders at the Meeting are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTES</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR</B></P></TD>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTES</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WITHHELD</B></P></TD>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTES</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGAINST</B></P></TD>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-weight: bold; text-align: center">ABSTENTIONS</TD>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BROKER</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NON-</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTES</B></P></TD>
    <TD NOWRAP STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCFFCC">
    <TD>1.&nbsp;Election of seven directors:</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="width: 24%">Dr. Irit Arbel</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: right">39,314,902</TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 12%; text-align: right">352,005</TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 15%; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCFFCC">
    <TD>Mordechai Friedman</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,316,402</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">350,505</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Dr. Abraham Israeli</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,539,902</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">127,005</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCFFCC">
    <TD>Alon Pinkas</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,316,252</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">350,655</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Chen Schor</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,540,252</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">126,655</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC">Dr. Robert Shorr</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">39,539,902</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">127,005</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>Malcolm Taub</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,541,402</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">125,505</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCFFCC">
    <TD>2. Approve compensation</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">39,037,255</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">N/A</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">566,882</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">62,770</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">34,097,005</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC; text-indent: -9pt">3. 3. Approve future compensation:</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">See below</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">265,870</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Every 1 Year</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2,000,333</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC; text-indent: -9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Every 2 Years</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">94,310</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Every 3 Years</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">37,306,394</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC; text-indent: -9pt">&nbsp;&nbsp;&nbsp; 4. Amendment and Restatement of the Plans (increase shares)</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">38,142,969</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">1,426,868</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">97,070</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC; text-indent: -9pt">&nbsp;&nbsp;&nbsp; 5. Amendment and Restatement of the Global Plan (equity-based awards)</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">38,710,104</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">862,765</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">94,038</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">34,097,005</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="background-color: #CCFFCC; text-indent: -9pt">&nbsp;&nbsp;&nbsp; 6. Ratification of Brightman Almagor Zohar &amp; Co</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">73,484,162</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">N/A</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">272,965</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">6,785</TD>
    <TD NOWRAP STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC">&nbsp;</TD>
    <TD STYLE="background-color: #CCFFCC; text-align: right">0</TD>
    <TD NOWRAP STYLE="background-color: white">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item&nbsp;9.01 Financial Statements and Exhibits. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The exhibits listed in the Exhibit&nbsp;Index below are filed
with this report.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>June 14, 2012</TD>
    <TD COLSPAN="2">Brainstorm Cell Therapeutics Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Liat Sossover</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Liat Sossover&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 90%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP COLSPAN="3" STYLE="border-bottom: black 1pt solid; text-align: center">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD NOWRAP STYLE="border-bottom: black 1pt solid">Description</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">10.1</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Brainstorm Cell Therapeutics Inc. Amended and Restated 2004 Global Share Option Plan is incorporated herein by reference to Exhibit A to the Registrant&rsquo;s Definitive Schedule&nbsp;14A filed May 7, 2012 (File No.&nbsp;000-54365).</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="text-align: right">&nbsp;</TD>
    <TD STYLE="text-align: right">10.2</TD>
    <TD NOWRAP>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Brainstorm Cell Therapeutics Inc. Amended and Restated 2005 U.S. Stock Option and Incentive Plan is incorporated herein by reference to Exhibit B to the Registrant&rsquo;s Definitive Schedule&nbsp;14A filed May 7, 2012 (File No.&nbsp;000-54365).</TD></TR>
<TR STYLE="vertical-align: top">
    <TD NOWRAP STYLE="padding-top: 6pt; text-align: right"></TD>
    <TD STYLE="text-align: right">99.1</TD>
    <TD NOWRAP STYLE="padding-top: 6pt"></TD>
    <TD STYLE="padding-top: 6pt"></TD>
    <TD>Description of Brainstorm Cell Therapeutics Inc. Amended and Restated 2004 Global Share Option Plan and Brainstorm Cell Therapeutics Inc. Amended and Restated 2005 U.S. Stock Option and Incentive Plan, each as amended and restated, is incorporated herein by reference to Proposal No.&nbsp;4 &amp; 5&nbsp; (pages 11 through 17) of the Registrant&rsquo;s Definitive Schedule&nbsp;14A filed May 7, 2012 (File No.&nbsp;000-54365).&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v315879_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 43895}]
{"company-data": {"conformed-name": "BRAINSTORM CELL THERAPEUTICS INC", "cik": "0001137883", "assigned-sic": "2836", "irs-number": "912061050", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54365", "film-number": "12907399"}, "business-address": {"street1": "110 EAST 59TH STREET", "city": "NEW YORK", "state": "NY", "zip": "10019", "phone": "250-519-0553"}, "mail-address": {"street1": "110 EAST 59TH STREET", "city": "NEW YORK", "state": "NY", "zip": "10019"}, "former-company": [{"former-conformed-name": "GOLDEN HAND RESOURCES INC", "date-changed": "20030827"}, {"former-conformed-name": "WIZBANG TECHNOLOGIES INC", "date-changed": "20010409"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 
June 11, 2012
Brainstorm Cell Therapeutics Inc.
(Exact name of registrant as specified
in its charter)
Delaware
000-54365
20-8133057
(State or other jurisdiction of incorporation)
(Commission File No.)
(IRS Employer Identification No.)
605 Third Avenue, 34
th
Floor
New York, NY
10158
(Address of principal executive offices)
(Zip Code)
(646) 666-3188
(Registrant's telephone number,
including area code)
N/A
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(c)
On June 11, 2012, Brainstorm Cell Therapeutics Inc.
(the "Company") appointed
Adrian Harel, Ph.D., as its Chief Executive Officer. Dr. Harel
previously served as the Company's Chief Operating Officer and Acting Chief Executive Officer. In addition to his role as
Chief Executive Officer of the Company, Dr. Harel will continue to serve as the Company's Director of Research and Development.
There were no changes to Dr. Harel's employment terms in connection with the appointment as Chief Executive Officer.
The Company's Form 8-K filed
with the Securities and Exchange Commission on February 2, 2011 and the employment agreement filed as Exhibit 10.1 thereto are
incorporated herein by reference.
(e)
On June 12, 2012, at the Annual Meeting of Stockholders
of the Company, the Company's stockholders approved the amendment and restatement of the Company's 2004 Global Share
Option Plan (the "Global Plan") and 2005 U.S. Stock Option and Incentive Plan (collectively, the "Plans").
The amendment and restatement of the Plans was approved by the Company's Board of Directors, subject to the approval of the
Company's stockholders, and became effective with such stockholder approval on June 12, 2012. As a result of such stockholder
approval, the Plans were amended to increase the number of shares of the Company's common stock available for issuance under
the Plans by 9,000,000 shares, collectively, and the Global Plan was amended to provide for the issuance of restricted stock and
other equity-based awards under such plan.
A more complete description of the terms of the Plans and the
amendments thereto can be found in "Proposal No. 4 & 5 – Approval of Amendment and Restatement of 2004 Global
Share Option Plan and 2005 U.S. Stock Option and Incentive Plan" (pages 11 through 17) in the Company's definitive
proxy statement on Schedule 14A filed with the Securities and Exchange Commission on May 7, 2012. The foregoing descriptions are
qualified in their entirety by reference to the Plans filed as exhibits hereto, which exhibits are incorporated herein by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
As stated above in Item 5.02, the
2012 Annual Meeting of Stockholders of the Company (the "Meeting") was held on June 12, 2012. At the Meeting, the following
matters were voted upon by the stockholders of the Company:
1.
The election of seven directors until the next annual meeting of stockholders;
2.
The approval, on an advisory basis, of the compensation of the Company's named executive officers;
3.
The approval, on an advisory basis, of the frequency of future executive compensation advisory votes;
4.
The amendment and restatement of the  Plans to increase the number of shares of the Company's common stock available for issuance thereunder by 9,000,000 shares, collectively;
5.
The amendment and restatement of the Global Plan to provide for the issuance of restricted
    stock and other equity-based awards under such plan; and
6.
The ratification of the appointment of Brightman Almagor & Zohar Co., a member of Deloitte Touche Tohmatsu, as the Company's independent registered public accounting firm for the current fiscal year.
The number of shares of common stock issued,
outstanding and eligible to vote at the Meeting as of the record date of April 23, 2012 was
127,961,217
.
Each of the matters voted upon at the Meeting was approved by the requisite number of votes. The final results of the voting on
each of the matters presented to stockholders at the Meeting are as follows:
VOTES
FOR
VOTES
WITHHELD
VOTES
AGAINST
ABSTENTIONS
BROKER
NON-
VOTES
1. Election of seven directors:
Dr. Irit Arbel
39,314,902
352,005
N/A
N/A
34,097,005
Mordechai Friedman
39,316,402
350,505
N/A
N/A
34,097,005
Dr. Abraham Israeli
39,539,902
127,005
N/A
N/A
34,097,005
Alon Pinkas
39,316,252
350,655
N/A
N/A
34,097,005
Chen Schor
39,540,252
126,655
N/A
N/A
34,097,005
Dr. Robert Shorr
39,539,902
127,005
N/A
N/A
34,097,005
Malcolm Taub
39,541,402
125,505
N/A
N/A
34,097,005
2. Approve compensation
39,037,255
N/A
566,882
62,770
34,097,005
3. 3. Approve future compensation:
See below
N/A
N/A
265,870
34,097,005
Every 1 Year
2,000,333
Every 2 Years
94,310
Every 3 Years
37,306,394
4. Amendment and Restatement of the Plans (increase shares)
38,142,969
N/A
1,426,868
97,070
34,097,005
5. Amendment and Restatement of the Global Plan (equity-based awards)
38,710,104
N/A
862,765
94,038
34,097,005
6. Ratification of Brightman Almagor Zohar & Co
73,484,162
N/A
272,965
6,785
0
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The exhibits listed in the Exhibit Index below are filed
with this report.
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
June 14, 2012
Brainstorm Cell Therapeutics Inc.
By:
/s/ Liat Sossover
Liat Sossover
Chief Financial Officer
EXHIBIT INDEX
Exhibit No.
Description
10.1
Brainstorm Cell Therapeutics Inc. Amended and Restated 2004 Global Share Option Plan is incorporated herein by reference to Exhibit A to the Registrant's Definitive Schedule 14A filed May 7, 2012 (File No. 000-54365).
10.2
Brainstorm Cell Therapeutics Inc. Amended and Restated 2005 U.S. Stock Option and Incentive Plan is incorporated herein by reference to Exhibit B to the Registrant's Definitive Schedule 14A filed May 7, 2012 (File No. 000-54365).
99.1
Description of Brainstorm Cell Therapeutics Inc. Amended and Restated 2004 Global Share Option Plan and Brainstorm Cell Therapeutics Inc. Amended and Restated 2005 U.S. Stock Option and Incentive Plan, each as amended and restated, is incorporated herein by reference to Proposal No. 4 & 5  (pages 11 through 17) of the Registrant's Definitive Schedule 14A filed May 7, 2012 (File No. 000-54365).